Medgenome Inc.
Foster City, CA
- UEI
- Z5KLLZJLJKM5
- CAGE
- 7QJR3
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 348 Hatch Dr, Foster City, CA 94404, USA
- Website
- medgenome.com
- Founded
- 2013
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $5,675 |
| FY2023 | $24,320 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Twinstrand Biosciences Inc. | Seattle, WA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Expression Analysis | Durham, NC | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Invitae Corporation | — | 621511 Medical Laboratories |
| Dovetail Genomics LLC | Scotts Valley, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Labcorp Genetics Inc. | Burlington, NC | 621511 Medical Laboratories |
About the company
Medgenome Inc. is a for-profit corporate entity headquartered in Foster City, California, specializing in scientific services within the genomics and laboratory testing domains. Registered in the System for Award Management (SAM.gov) since October 2016, the company provides advanced genomic sequencing, lab testing, and DNA/RNA extraction services primarily to federal research institutions. The company has maintained an active federal contracting presence, with its current SAM.gov registration valid through July 18, 2025, positioning it as a small business capable of delivering specialized scientific research services to government agencies.
The federal contract awards for Medgenome Inc. demonstrate a consistent focus on genomic and laboratory research across multiple federal agencies, including the National Institutes of Health (NIH), National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, and the U.S. Geological Survey. The company has been awarded multiple purchase order contracts ranging from $5,675 to $24,500, with specific project scopes including genomic sequencing and data services, lab testing services, and specialized research such as delineating the transcriptome of human brown/beige adipocytes. None of the contracts were set aside exclusively, though one was designated as a total small business contract. The contracts have involved detailed scientific work, typically with completion dates between 2020 and 2025, indicating Medgenome's ongoing capability to support federal research initiatives through precise, targeted genomic and laboratory analysis services.
Quick answers
Is Medgenome Inc. registered in SAM.gov?
Yes. Medgenome Inc.'s SAM.gov registration is active through January 28, 2027.
How much has Medgenome Inc. received in federal contracts?
Federal contracts obligated $29,995 to Medgenome Inc. in fiscal years 2023 through 2027.
What is Medgenome Inc.'s most recent federal award?
Medgenome Inc.'s most recent federal contract award is Genomic sequencing and data (140G0324P0363), from Office of Acquisitions and Grants (USGS), on August 29, 2024.
On GovTribe
See Medgenome Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors